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LACTATE PRODUCTION AND LACTATE DEHYDROGENASE IN
THE HUMAN EPIDERMIS*
KENNETH M. HALPRIN, M.D. AND AKIRA OHKAWARA, M.D.
Several investigators (1, 2, 3, 4) have estab-
lished that epidermis converts most of the glu-
cose it uses to lactic acid even in the presence
of oxygen. This is in contrast to most tissues
where lactic acid production is used for energy
production only when oxygen is not available.
This large amount of lactic acid being continu-
ally produced within the epidermal cell must
be excreted by the cell and then carried away
by the blood stream to other tissues where the
lactate can be utilized.
The enzymatic reaction which leads di-
rectly to the production of lactate from pyru-
vate is catalyzed by the enzyme lactate dehy-
drogenase (LDH) and requires the presence of
reduced diphosphopyridine nucleotide as the
hydrogen donor (NADH) (Fig. 1). This reac-
tion is reversible although at physiological pH
the equilibrium position for the reaction lies
very far to the right, i.e., in favor of lactate
production. The speed of this reaction depends
not only on the amount of enzyme present but
also on the concentrations of the substances in-
volved on both sides of the equation. The net
direction in which the reaction will proceed
depends solely on the relative concentrations of
the substances on each side of the equation.
In vivo there is net conversion of pyruvate
(formed from glucose) to lactate. Measure-
ments of the speed of lactate production by
sheets of epidermis floating on a medium con-
taining glucose indicate a rate of lactate pro-
duction of approximately 0.7 rn/sm/mm/mg of
fresh epidermis (1, 2). By contrast, when
LDII is assayed under optimal conditions in
homogenates of human epidermis, a rate of ap-
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proximately 35 m/sm/rnin/mg at 25° C is
found (5) and this at 37° C would probably
rise to about 70 rn/sm/mm/mg, a figure which
approximates that found by Hershey et al.
(6). This is approximately 100 times the rate
of lactate formation observed in the slice incu-
bation experiments.
The slice incubation experiments are pre-
sumably much closer to the actual in vivo con-
ditions than the homogenate experiments. The
discrepancy between the two indicates that in
vivo conditions are far from optimal for the
conversion of pyruvate to lactate. Only /iooth
of the maximal activity of the enzyme present
is being achieved.
The optimal conditions used in the in vitro
homogenate assays for the conversion of pyru-
vate to lactate are the presence of high con-
centrations of pyruvate and NADH and the
absence of lactate and oxidized diphosphopyri-
dine nueleotide (NAn). The concentrations of
the various substances involved are not optimal
in vivo since pyruvate and NADH concentra-
tions are lower than lactate and NAD concen-
trations (5) and this might explain the in vivo
inhibition of LDH activity. Other factors which
might explain the discrepancy between the
slice experiments and the homogenate assays
include (a) the presence of an inhibitor(s) in
vivo which is not present in the homogenate
assay because of dilution factors, and (b) the
effects of intracellular organization which might
prevent ready access of substrate to enzyme in
vivo, but would not affect the homogenate as-
says where cellular organization has been com-
pletely disrupted.
This study was done to try to evaluate the
factors responsible for the presumed in vivo
inhibition of LDH to only Yiooth of its possible
maximum activity.
MATERIALS AND METHODS
The use of the Castroviejo keratome to obtain
02 mm thick skin strips from the backs of 20—25
year old caucasian men has been described (5) as
has the assay system for lactate, pyruvate, NAD,
NADH, and lactate dehydrogenase (5).
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RESULTS
1. In vivo Studies of Enzyme and
Substrate Corwent rations
Table 1 lists the in vivo concentrations of
the various substrates of the reaction and the
LDH activity as measured at 25° C in the pres-
ence of 0.7 sm/cc pyruvate and 0.12 cm/cc
NADII.
2. In Vitro Studies of Epiderma LDH
a. pH activity curve.—Figure 2 demon-
strates that maximal activity of LDH occurs
in the region of pH 7.0—7.5. This is presumably
close to the in vivo pH and is also the pH at
which the in vitro measurements are made
(pH 7.4). The discrepancy between the ho-
mogenate activity and the slice experiments is,
therefore, probably not due to the presence of
an unphysiologic pH.
b. Effect of pyruvate concentration on LDH
GLUCOSE
(DPNH) LO (DPN)
PYRUVATE ÷ NAGH ll> LACTATE + HAD
COO— COO-
C=O HO—CR
CR3 Cl-I3
FIG. 1. Reaction catalyzed by LDH
/77 Pyruvate data in presence of/ 0.OI2pm/ccDPNH(I DPNH data in presence of/ 0.7 pm/cc Pyruvote
I I
£ Pyruvote 0 .1 .2 .3 .4 .5 .6
S DPNH 0 .005 .010 .015 .020 .025 .030
urn/cc
Fio. 3. Effects of pyruvate and NADH concen-
trations on LDH activity.
£ Pyruvote 0 .02 .04 .06
•DPNH 0 .2 .4 .6
I/S(xlO° M)
FIG. 4. Lineweaver-Burke plot of the effect of
pyruvate and NADU concentrations on LDH
activity.
activity.—Figure 3 demonstrates the effect of
the pyruvate concentration on the maximal
velocity. Saturation of the enzyme is reached
at pyruvate concentrations above 0.7 x 10' M.
Figure 4 is a Lineweaver-Burke plot of 1/V
versus 1/S for pyruvate demonstrating a
Michaelis constant (Km) (substrate concen-
tration where velocity is ½ maximal) of 2.5 x
10 M.
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Since the in vivo concentration of pyruvate
is well above the Km (Table 1), a lack of pyru-
vate within the cell cannot explain the lack of
lopH LDH activity in vivo.
Fia. 2. pH activity curve of LDH c. Effect of NADH (DPNH) concentration
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Substance
Concentration
mm/mg tissue
m/m/pl tissue 1120
(Based on of the tissue
being water)
Pyruvate
Lactate
NADII
NAB
1.3 0.6 (8)
17.3 (11.2 and
23.4) (2)**
0.008 (0.012 and
0.003) (2)
0.20 h0.03 (7)
1.9 (1.9 X 10M)
26.0 (2.6X102M)
0.012 (1.2 X lOsM)
0.30(3.0X104M)
on activity of LDH.—Figures 3 and 4 demon-
strate activity versus concentration data for
NADH. The in vivo concentration of NADU
(Table 1) is some 3—4 times the Km of 3.3 x
10 M and again the lack of LDH activity
cannot be due to a lack of NADU within the
cell.
d. Effect of lactate concentration on LDH
activity.—Figure 5 demonstrates the effect of
the lactate concentration on LDII activity.
The amount of pyruvate, DPN, and DPNH in
the assay tube were chosen to be close to
physiological. At a lactate concentration of
approximately 20 tm/ce which is close to the
in vivo situation LDH still converts pyruvate
into lactate at some 70% of its maximal activity.
e. Effect of NAD concentration on LDH
activity.—Figure 6 demonstrates the effect of
the NAD concentration on LDH activity. At
the physiological concentration of 0.3 Lm/cc
some 70% of maximum velocity is present.
f. Reconstruction of oil physiological con-
centratjons.—When all of the substrates and
products are put together in physiological con-
centrations (Table 2) the activity of LDII is
still 68% of maximum.
g. Measurements of the effects of different
ratios of reactants and of the equilibrium con-
dition of LDH.—The equilibrium condition for
00° Pyruvate 0.5 urn/cc
DPNH 0.01
Lactate 10.0
50-
25
0 0.5 1.0 .5 2.0
DPN concentration —pm/cc
FIG. 6. Effect of NAD concentration on LDH
activity.
LDH activity at physiological concentrat ions
of substrates
Concentrations of Substrates
% of Maximum
velocity in .05 M
Tris nser pH 7.4
® 25°C.
NADH (.01 pm/cc)
NAD (0.3 pm/cc)
Pyruvate (1.5 pm/cc)
Lactate (30.0 pm/cc)
68%
TABLE 1
In vivo concentration of LDH and substrates
* Lactate dehydrogenase activity =
36.0 14.7 (11)
* Activity in niillimicromoles of pyruvate con-
verted to lactate per minute per milligram of fresh
epidermis @ pH 7.4 and 25° C. + ( ) indicates
the number of specimens the value is based upon
** earlier figures based on nine specimens gave a
value of 20.2 5.7. The commercial preparation
of lactate dehydrogenase (Sigma) used for the
assay of lactate, however, caused some oxidation
of NADH even in the absence of substrate and
the former figure of 29.2 is therefore too high.
Current figures have been corrected for this
spurious NADH oxidation.
tOO Pyruvate 0.5 pm/cc
DPN 0.1
DPNH 0.01
50
25
-0 25 50 75 00
Lactate concentration —pm/cc
FIG. 5. Effect of lactate concentration on LDH
activity.
TABLE 2
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epidermal LDH is much in favor of the produc-
tion of lactate and NAD from pyruvate and
NADH. In order to prevent the net formation
of lactate and NAD, the concentration of lac-
tate and NAD present in the reaction vessel
must be very high and the concentration of
NADH and pyruvate very low. Measurements
of the equilibrium position (Keq) at which no
net formation of any of the reactants is occur-
ring shows that the product of the ratios
NAD/NADH x Lactate/Pyruvate must be of
the order of 100,000 (10). If the product of the
ratios is higher than this the reaction will re-
verse and pyruvate and NADH will be formed
at the expense of lactate and NAD, while if it
is lower the reverse will occur. Figure 7 demon-
strates the percent of maximal velocity of lac-
tate formation for various values of the product
of the ratios of NAD/NADH and Lactate/
Pyruvate.
The physiological ratios are
NAD 0.3 Lactate 30
and
NADH 0.01 Pyruvate 1.5
The product of their ratios would be 600 which
is very far to the left on the curve and would
not depress the formation of lactate and NAD
from pyruvate and NADH. Ten fold increases
in both NAD and lactate would be needed to
stop lactate formation.
3. In Vitro Studies for the Presence of
an Inhibitory Substance
The second possibility considered to account
for the discrepancy in activities between the
slice and homogenate results was the presence
of an inhibitory substance in the slice prepara-
tion (and in vivo). Such a substance would be
active in vivo and in the slice, but when the
epidermal homogenate is made up the inhibitor
would be diluted (100 mg of tissue is homoge-
nized in 1 cc of buffer giving a 1:10 dilution)
and its effect would not be present to the same
extent in the homogenate. In the assay proce-
dure 10 pl of homogenate are added to 1 cc of
buffer for assay and again dilution of the in-
hibitor of 1:100 would occur.
To test for such an inhibitor various dilutions
of homogenate were assayed. If an inhibitor
were present the measured LDH activity
would show a non-linear activity versus con-
centration curve. As higher dilutions of ho-
Fia. 7. Effect of varying ratios of substrates on
LDH activity.
TABLE 3
Effect of honwqenate dilution on LDH
activity
Homogenate dilution Velocity
1/10
1/20
1/44)
5 m,m/min
2.5 mpm/min
1.27 mim/min
LDH activity measured in presence of 0.7
pm/cc pyruvate and 0.10 pm/cc NADH.
mogenate were made, the inhibitor would be
less effective and LDH activity would be
higher than the activity predicted on the basis
of dilution alone. Table 3 demonstrates that
this is not the case and activity varies quite
linearly with dilution. This is evidence against
any significant amount of inhibitor being pres-
ent.
DISCUS5ION
Human epidermal cells contain a large
amount of lactate dehydrogenase. Our results
and those of Hershey et at. (6) indicate that
this amount of LDH is capable of turning ap-
proximately 70 mpm of pyruvate into lactate
per minute per milligram of epidermis at
37 C. These results are obtained using epider-
mal homogenates and an assay system which
assures the maximal possible rate—i.e., the
presence of saturating, amounts of pyruvate
0 4 8 12 16 100
Lactate x DPN x
Pyruvate x DPNH
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and NADH and the absence of lactate, NAD,
or other known inhibitors in the assay tube.
By contrast, the rate of lactate production
by a slice of epidermis floating on an incuba-
tion medium containing glucose is only 0.7
mm/min/mg of epidermis (1, 2). This rate of
lactate formation is some 100 times less than
the measured capability of the amount of lac-
tate dehydrogenase present within the tissue as
measured by the in vitro homogenate assay.
The inhibition of LDH which occurs in the
slice preparation and also presumably in vivo
cannot be explained simply by a lack of pyru-
vate or NADH within the tissue or by an ex-
cess of the products lactate and NAD. Our re-
sults indicate that the concentrations of these
substances present in vivo would allow LDH
activity to proceed at a rate of about 70% of
maximal if all the substrates and products were
freely accessible to the enzyme.
Also the inhibition of LDH within the tissue
cannot be explained by an inhibitory substance
which is present within the tissue, but which is
not directly concerned in the reaction. Absence
of any such inhibitory substance was demon-
strated by the homogenate dilution experiment.
We are forced to conclude that the condi-
tions in the slice experiments and in vivo
which limit the utilization of LDH activity to
about 1% of its maximum have not been
demonstrated by our experiments and are pre-
sumably due to the effects of intracellular or-
ganization. LDH presumably exists in a highly
specific site upon cellular membranes. It has
been shown by Hershey et at. (6) to sediment
in both the mitochondrial and supernatant
fractions on centrifugation of epidermal ho-
mogenates. In these locations access of sub-
strates to the enzyme is presumably severely
limited although the cell as a whole has an
adequate amount of these substances.
LDH is present in high concentration and
catalyzes a reaction which is practically irre-
versibly in favor of lactate formation at
physiological pH (Keq = 10'). If its activity
within the cell were not so severely limited the
pyruvate concentration within the cell would
fall to negligible amounts due to its rapid con-
version to lactate. The absence of pyruvate
within the cell, a source of substrates for the
tricarboxylic acid cycle and a source of lipids
and amino acids, would obviously pose a severe
metabolic problem for the cell. The cellular
organization which limits LDH activity and
thereby keeps a useful concentration of pyru-
vate within the cell is obviously serving a neces-
sary function. The unraveling of this mecha-
nism of inhibition would be most useful not
only in terms of the control of LDH activity
but also in explaining the controlling mecha-
nism for other enzymes within the cell.
SUMMARY AND CONCLUSIONS
Experiments using slices of epidermis float-
ing on tissue culture media containing glucose
demonstrate a production of lactate which is
100 times less than the maximal measurable
rate of lactate production in epidermal ho-
mogenates. The epidermal slice with its intact
cellular organization is presumably close to the
in vivo situation and therefore implies that in
vivo lactate dehydrogenase is inhibited to the
point where only about 1% of its maximal ac-
tivity is being utilized.
Measurements of the in vivo concentrations
of the substrates and products of the LDH re-
action demonstrate that the inhibition of LDH
activity in vivo cannot be due to a lack of sub-
strates or an excess of products within the cell.
Furthermore, no inhibitors of this reaction are
demonstrable within the epidermal homogenate.
We are forced to conclude that the inhibition
of LDH activity within the cell must be due
to the facts of cellular organization; that al-
though substrate concentrations within the cell
are adequate, these substrates are prevented
from gaining access to the LDH and are there-
fore in effect in very low concentration at the
active site of the enzyme.
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